Metolazone
-
Identifiers
CAS number
17560-51-9Molecular formula
C16H16ClN3O3SSMILES
CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
Safety labels
Irritant -
Odor profile
Fragrance Odorless 79.86% Bitter 21.94% Cooked 20.38% Savory 19.46% Roasted 16.31% Grape 15.79% Meaty 15.44% Burnt 15.21% Cooling 13.86% Milky 13.08% Flavor Bitter 92.88% Odorless 32.62% Bland 19.87% Nitrile 19.64% Very strong 18.35% Cedarleaf 18.33% Sweet-like 18.31% Indole 18.08% Taco 18.01% Bread crust 17.91% Odor impact est.
Odorless -
Properties
XLogP3-AA
4.1pKa est.
7.82 (neutral)Molecular weight
365.8 g/molVapor pressure est.
- hPa @ 20°C
- hPa @ 25°C
Evaporation rate
Ultra slowBoiling point est.
596°CMelting point expt.
- 256 °C
- 253-259 °C
Flash point
- 283.91 ˚C est.
Solubility expt.
- 60.3 mg/L (at 25 °C)
- INSOL IN WATER & ALCOHOL
- 4.07e-02 g/L
-
Synonyms
- metolazone
- 17560-51-9
- Zaroxolyn
- Mykrox
- Diulo
- Oldren
- Metenix
- Metalozone
- Microx
- Metolazona
- Metolazonum
- metozalone
- Xuret
- 7-Chloro-2-methyl-4-oxo-3-(o-tolyl)-1,2,3,4-tetrahydroquinazoline-6-sulfonamide
- Metolazonum [INN-Latin]
- Metolazona [INN-Spanish]
- 6-Quinazolinesulfonamide, 7-chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-
- SR 720-22
- SR-720-22
- Metazoline
- Normelan
- 7-Chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide
- Metolazone (Zaroxolyn)
- 7-Chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-o-tolyl-6-quinazolinesulfonamide
- HSDB 3367
- 2-Methyl-3-o-tolyl-6-sulfamyl-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone
- UNII-TZ7V40X7VX
- EINECS 241-539-3
- TZ7V40X7VX
- NSC-759581
- 7-chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide
- BRN 0965506
- DTXSID6045167
- Metolazone, (+)-
- Metolazone, (-)-
- CHEBI:64354
- 7-chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2,3,4-tetrahydroquinazoline-6-sulfonamide
- MFCD00069304
- NM7V2Y3G0U
- 6-Quinazolinesulfonamide, 7-chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-o-tolyl-
- DTXCID4025167
- 5-25-09-00212 (Beilstein Handbook Reference)
- 6-Quinazolinesulfonamide, 1,2,3,4-tetrahydro-7-chloro-2-methyl-4-oxo-3-o-tolyl-
- NN9U607695
- NSC 759581
- Metolazone [USAN:USP:INN:BAN:JAN]
- NCGC00093985-07
- Metalazone
- Metolazonum (INN-Latin)
- Metolazona (INN-Spanish)
- METOLAZONE (MART.)
- METOLAZONE [MART.]
- METOLAZONE (USP-RS)
- METOLAZONE [USP-RS]
- 56436-32-9
- METOLAZONE (EP IMPURITY)
- METOLAZONE [EP IMPURITY]
- METOLAZONE (EP MONOGRAPH)
- METOLAZONE [EP MONOGRAPH]
- METOLAZONE (USP MONOGRAPH)
- METOLAZONE [USP MONOGRAPH]
- Metolazone (USAN:USP:INN:BAN:JAN)
- Zaroxolyn (TN)
- 56436-31-8
- 6-Quinazolinesulfonamide, 7-chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-, (+)-
- 6-Quinazolinesulfonamide, 7-chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-, (-)-
- SMR001230730
- SR-05000001765
- Metolazon
- Metolazone (JAN/USP/INN)
- Metolazone; (2RS)-7-Chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2,3,4-tetrahydroquinazoline-6-sulfonamide
- Prestwick_333
- CAS-17560-51-9
- Metolazone (Standard)
- Spectrum_000456
- METOLAZONE [MI]
- METOLAZONE [INN]
- METOLAZONE [JAN]
- Prestwick0_000112
- Prestwick1_000112
- Prestwick2_000112
- Prestwick3_000112
- Spectrum2_001741
- Spectrum4_000229
- Spectrum5_001237
- METOLAZONE [HSDB]
- METOLAZONE [USAN]
- METOLAZONE [VANDF]
- CHEMBL878
- UNII-NM7V2Y3G0U
- METOLAZONE [WHO-DD]
- SCHEMBL40558
- BSPBio_000124
- BSPBio_002422
- KBioGR_000897
- KBioSS_000936
- MLS002153316
- MLS002154200
- DivK1c_000275
- SPECTRUM2300325
- SPBio_001842
- SPBio_002063
- BPBio1_000138
- GTPL4838
- METOLAZONE [ORANGE BOOK]
- UNII-NN9U607695
- BDBM25899
- HMS500N17
- HY-B0209R
- KBio1_000275
- KBio2_000936
- KBio2_003504
- KBio2_006072
- C03BA08
- NINDS_000275
- BCPP000166
- HMS1568G06
- HMS1922L16
- HMS2093P14
- HMS2095G06
- HMS2230J15
- HMS3261J22
- HMS3373C11
- HMS3655M09
- HMS3712G06
- HMS3744I19
- Pharmakon1600-02300325
- BCP21574
-
Applications
Metolazone (CAS 17560-51-9) is a thiazide-like diuretic primarily used as an active pharmaceutical ingredient for the treatment of hypertension and edema; in pharmaceutical manufacturing it functions as the API and can serve as a building block for the synthesis of related diuretic agents; in research and development settings it is often employed as an intermediate or reference compound for organic synthesis toward thiazide analogs; in analytical laboratories it supports method development, calibration, and quality control; its use is subject to local pharmaceutical regulations and formulation constraints.
gpt-5-nano
-
Solubility @25˚C
Solvent Solubility (g/L) ethanol 2.64 methanol 7.96 isopropanol 1.11 water 0.04 ethyl acetate 2.75 n-propanol 1.8 acetone 9.98 n-butanol 1.07 acetonitrile 4.47 DMF 111.47 toluene 0.08 isobutanol 0.78 1,4-dioxane 4.52 methyl acetate 3.88 THF 12.89 2-butanone 8.97 n-pentanol 0.61 sec-butanol 0.81 n-hexane 0.0 ethylene glycol 3.61 NMP 63.19 cyclohexane 0.01 DMSO 40.39 n-butyl acetate 2.23 n-octanol 0.3 chloroform 1.48 n-propyl acetate 2.24 acetic acid 8.98 dichloromethane 1.83 cyclohexanone 8.26 propylene glycol 5.6 isopropyl acetate 1.44 DMAc 93.46 2-ethoxyethanol 11.89 isopentanol 0.79 n-heptane 0.01 ethyl formate 4.77 1,2-dichloroethane 1.27 n-hexanol 0.4 2-methoxyethanol 39.82 isobutyl acetate 1.08 tetrachloromethane 0.08 n-pentyl acetate 1.89 transcutol 11.51 n-heptanol 0.52 ethylbenzene 0.06 MIBK 1.74 2-propoxyethanol 12.75 tert-butanol 0.7 MTBE 0.3 2-butoxyethanol 6.19 propionic acid 4.14 o-xylene 0.08 formic acid 14.46 diethyl ether 0.44 m-xylene 0.08 p-xylene 0.14 chlorobenzene 0.45 dimethyl carbonate 5.42 n-octane 0.01 formamide 27.65 cyclopentanone 21.48 2-pentanone 4.16 anisole 0.84 cyclopentyl methyl ether 0.86 gamma-butyrolactone 25.09 1-methoxy-2-propanol 20.82 pyridine 5.12 3-pentanone 2.54 furfural 27.73 n-dodecane 0.01 diethylene glycol 17.41 diisopropyl ether 0.08 tert-amyl alcohol 0.58 acetylacetone 9.39 n-hexadecane 0.01 acetophenone 2.62 methyl propionate 4.5 isopentyl acetate 1.92 trichloroethylene 4.61 n-nonanol 0.36 cyclohexanol 0.42 benzyl alcohol 1.9 2-ethylhexanol 0.31 isooctanol 0.48 dipropyl ether 0.5 1,2-dichlorobenzene 0.64 ethyl lactate 4.71 propylene carbonate 9.02 n-methylformamide 30.97 2-pentanol 0.35 n-pentane 0.01 1-propoxy-2-propanol 6.81 1-methoxy-2-propyl acetate 6.65 2-(2-methoxypropoxy) propanol 6.74 mesitylene 0.06 ε-caprolactone 7.54 p-cymene 0.17 epichlorohydrin 16.77 1,1,1-trichloroethane 0.56 2-aminoethanol 5.96 morpholine-4-carbaldehyde 50.73 sulfolane 35.22 2,2,4-trimethylpentane 0.0 2-methyltetrahydrofuran 1.97 n-hexyl acetate 1.37 isooctane 0.0 2-(2-butoxyethoxy)ethanol 7.16 sec-butyl acetate 1.04 tert-butyl acetate 1.39 decalin 0.01 glycerin 19.91 diglyme 15.83 acrylic acid 6.62 isopropyl myristate 0.61 n-butyric acid 4.68 acetyl acetate 2.49 di(2-ethylhexyl) phthalate 2.04 ethyl propionate 2.03 nitromethane 36.87 1,2-diethoxyethane 2.27 benzonitrile 2.38 trioctyl phosphate 1.05 1-bromopropane 0.27 gamma-valerolactone 53.34 n-decanol 0.27 triethyl phosphate 1.65 4-methyl-2-pentanol 0.26 propionitrile 2.53 vinylene carbonate 9.16 1,1,2-trichlorotrifluoroethane 23.64 DMS 3.06 cumene 0.06 2-octanol 0.26 2-hexanone 2.29 octyl acetate 0.93 limonene 0.19 1,2-dimethoxyethane 15.7 ethyl orthosilicate 1.23 tributyl phosphate 1.25 diacetone alcohol 5.66 N,N-dimethylaniline 0.66 acrylonitrile 7.0 aniline 0.76 1,3-propanediol 8.29 bromobenzene 0.27 dibromomethane 0.58 1,1,2,2-tetrachloroethane 3.05 2-methyl-cyclohexyl acetate 1.96 tetrabutyl urea 2.54 diisobutyl methanol 0.25 2-phenylethanol 1.98 styrene 0.1 dioctyl adipate 1.95 dimethyl sulfate 13.25 ethyl butyrate 2.23 methyl lactate 11.67 butyl lactate 3.85 diethyl carbonate 1.96 propanediol butyl ether 4.54 triethyl orthoformate 1.93 p-tert-butyltoluene 0.14 methyl 4-tert-butylbenzoate 4.57 morpholine 8.88 tert-butylamine 0.15 n-dodecanol 0.19 dimethoxymethane 22.23 ethylene carbonate 6.05 cyrene 15.18 2-ethoxyethyl acetate 5.27 2-ethylhexyl acetate 1.35 1,2,4-trichlorobenzene 1.19 4-methylpyridine 2.69 dibutyl ether 0.32 2,6-dimethyl-4-heptanol 0.25 DEF 7.93 dimethyl isosorbide 14.51 tetrachloroethylene 1.42 eugenol 6.86 triacetin 4.55 span 80 4.27 1,4-butanediol 2.36 1,1-dichloroethane 0.66 2-methyl-1-pentanol 0.57 methyl formate 19.65 2-methyl-1-butanol 0.73 n-decane 0.01 butyronitrile 2.0 3,7-dimethyl-1-octanol 0.32 1-chlorooctane 0.08 1-chlorotetradecane 0.04 n-nonane 0.01 undecane 0.01 tert-butylcyclohexane 0.01 cyclooctane 0.0 cyclopentanol 1.23 tetrahydropyran 0.99 tert-amyl methyl ether 0.35 2,5,8-trioxanonane 11.82 1-hexene 0.04 2-isopropoxyethanol 4.4 2,2,2-trifluoroethanol 4.8 methyl butyrate 3.51 Scent© AI
| Maximum acceptable concentrations in the finished product (%) | |||
|---|---|---|---|
|
Category 1
Products applied to the lips
|
No restriction |
Category 7A
Rinse-off products applied to the hair with some hand contact
|
No restriction |
|
Category 2
Products applied to the axillae
|
No restriction |
Category 7B
Leave-on products applied to the hair with some hand contact
|
No restriction |
|
Category 3
Products applied to the face/body using fingertips
|
No restriction |
Category 8
Products with significant anogenital exposure
|
No restriction |
|
Category 4
Products related to fine fragrance
|
No restriction |
Category 9
Products with body and hand exposure, primarily rinse off
|
No restriction |
|
Category 5A
Body lotion products applied to the body using the hands (palms), primarily leave on
|
No restriction |
Category 10A
Household care products with mostly hand contact
|
No restriction |
|
Category 5B
Face moisturizer products applied to the face using the hands (palms), primarily leave on
|
No restriction |
Category 10B
Household care products with mostly hand contact, including aerosol/spray products (with potential leave-on skin contact)
|
No restriction |
|
Category 5C
Hand cream products applied to the hands using the hands (palms), primarily leave on
|
No restriction |
Category 11A
Products with intended skin contact but minimal transfer of fragrance to skin from inert substrate without UV exposure
|
No restriction |
|
Category 5D
Baby Creams, baby Oils and baby talc
|
No restriction |
Category 11B
Products with intended skin contact but minimal transfer of fragrance to skin from inert substrate with potential UV exposure
|
No restriction |
|
Category 6
Products with oral and lip exposure
|
No restriction |
Category 12
Products not intended for direct skin contact, minimal or insignificant transfer to skin
|
No restriction |